Study of factors affecting the incidence of skin cancer in patients after liver transplant.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28954097)

Published in An Bras Dermatol on September 27, 2017


Gabriela Rached Campos1, Ilka de Fátima Santana Ferreira Boin2, Ivan Dias de Campos1, Maria Letícia Cintra3

Author Affiliations

1: Post-Graduation Program in Surgery Sciences of School of Medical Sciences of Universidade Estadual de Campinas (FCM-Unicamp) - Campinas (SP), Brazil.
2: Department of Surgery of School of Medical Sciences of Universidade Estadual de Campinas (FCM-Unicamp) - Campinas (SP), Brazil.
3: Department of Pathologic Anatomy of School of Medical Sciences of Universidade Estadual de Campinas (FCM-Unicamp) - Campinas (SP), Brazil.

Articles cited by this

Cutaneous squamous-cell carcinoma. N Engl J Med (2001) 7.31

Skin cancers after organ transplantation. N Engl J Med (2003) 6.65

Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation (1990) 2.07

The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation (1996) 1.75

Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis (1999) 1.75

Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol (2006) 1.74

A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol (2006) 1.49

Skin cancer in organ transplant recipients--where do we stand today? Am J Transplant (2008) 1.35

Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis (2000) 1.24

Photoprotection. J Am Acad Dermatol (2005) 1.16

Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol (2001) 1.07

De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer (1997) 1.06

Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98

Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg (2004) 0.97

Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg (2012) 0.97

Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl (2002) 0.97

Non-lymphoid cancer after liver transplantation. Hepatogastroenterology (1997) 0.94

Malignancy after liver transplantation: cumulative risk for development. Transplant Proc (2009) 0.83

[Skin disease in liver and kidney transplant recipients referred to the department of dermatology and venereology]. Acta Med Port (2013) 0.82

European multicenter tacrolimus heart pilot study: three year follow-up. J Heart Lung Transplant (2001) 0.79

Skin changes in pediatric transplant patients. Pediatr Transplant (2006) 0.78